NCT00004699View on ClinicalTrials.gov

Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 1995

Study Completion Date

January 31, 1999

Conditions
Hyperinsulinism
Interventions
DRUG

insulin-like growth factor I

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT00004699 - Dose Ranging Study of Recombinant Human Insulin-like Growth Factor I in Children With Hyperinsulinism | Biotech Hunter | Biotech Hunter